Literature DB >> 3715200

Neurotoxicity in rats following subchronic amiodarone treatment.

K S Rao, J C Fernando, I K Ho, H M Mehendale.   

Abstract

Rats were treated with amiodarone (20 mg/kg/day) up to 6 weeks and the neurotoxicity was assessed by determining changes in motor coordination, pain-threshold and rectal temperature every week during treatment. Body weight gain was decreased during amiodarone treatment and it was significant at and after 5 weeks. Food intake and water consumption were significantly reduced during treatment. After the first week of treatment with amiodarone, rats showed decreased ability to balance on horizontal rods. In the hot plate test (paw-lick), the amiodarone treated rats showed increased pain-thresholds throughout the treatment. Hypothermia was significant only at 6 weeks. These results show that amiodarone causes toxicity in rats and this model might be useful for further studies. Decreased motor-coordination, and increased pain-responding times may indicate development of peripheral neuropathy in addition to muscle weakness.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3715200

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  3 in total

1.  Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.

Authors:  C K Svensson; L L Liu; P W Knowlton
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

2.  Amiodarone and desethylamiodarone increase intrasynaptosomal free calcium through receptor mediated channel.

Authors:  P R Kodavanti; S N Pentyala; P R Yallapragada; D Desaiah
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

3.  Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolation.

Authors:  Engi Abd El-Hady Algharably; Emma Di Consiglio; Emanuela Testai; Reinhold Kreutz; Ursula Gundert-Remy
Journal:  Arch Toxicol       Date:  2021-02-19       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.